Trough to peak ratio of once-daily lisinopril and twice-daily captopril in patients with essential hypertension

Journal of Human Hypertension

Volumn 12, Issue 1, 1998, Pages 69-72

  Martell, N ^a   Gill, B ^b   Marin, R ^c   Suarez, C ^d   Tovar, J L ^e   Cia, P ^f   Fernandez, C ^a   Gonzalez, L ^b   Maldonado, A ^b   Fernandez F ^c   Del Arco, C ^d   Garcia, I ^d   Yuste, I ^f   Luque, M ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c Servicio de Geriatría   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e Hebron Hospital   (Spain)

^f Mutua de Accidentes   (Spain)

Author keywords

Antihypertensive drugs; Captopril; Lisinopril; Trough to peak ratio

Indexed keywords

CAPTOPRIL; LISINOPRIL;

ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE CALCULATION; DRUG BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 6844254527     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000545     Document Type: Article

References (10)

1. Mancia G, Di Rienzo M, Parati G. Ambulatory BP monitoring use in hypertension research and clinical practice. Hypertension 1993; 21: 510-524.
2. Lipicky RJ. Trough/peak ratio: the rationale behind the United States Food and Drug Administration recommendations. J Hypertens 1994; 12 (Suppl 8): S18-S19.
3. Zannand F, Matzinger A, Larche J. Trough/Peak ratios of once-daily angiotensin converting enzyme inhibitors and calcium antagonists. Am J Hypertens 1996; 9: 633-643.
4. Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory BP: methodological aspects. J Hypertens 19951; 13: 1105-1112.
5. Waeber B et al. Trials using crossover design and ambulatory BP recording to determine the efficacy of antihypertensive agents in individual patients. J Hypertens 1990; 8 (Suppl 4): S37-S42.
6. Whelton A et al. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressure. J Clin Pharmacol 1990; 30: 1074-1080.
7. Cirillo VJ et al. Lisinopril: dose peak effect relationship in essential hypertension. Br J Clin Pharmacol 1988; 25: 533-538.
8. General discussion on methodological aspects of the trough/peak measurement. J Hypertens 1994; 12 (Suppl 8): S27-S78.
9. Salvetti A et al. Trough:peak ratio of nifedipine gastrointestinal therapeutic system and nifedipine retard in essential hypertensive patients: an Italian multicentre study, J Hypertens 1996; 14: 661-667.
10. Zanchetti A. Trough:peak ratio of the BP response to dihydropyridine calcium antagonists. Italian Nifedipine GITS Study Group. J Hypertens 1994; 12 (Suppl 8): S97-S106.